CLINICAL_TRIALS
trial_result
· 2019-02-15
Clinical Trial Update: A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine [Phase 1]
Summary
Phase 1 dose-escalation study assessing safety of the P2-VP8 Rotavirus vaccine; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PATH | Conditions: Rotavirus Infection | Phase 1 | Status: COMPLETED | Results posted: 2019-02-15